Your browser doesn't support javascript.
loading
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.
Gasco, V; Giannelli, J; Campioni, L; Arvat, E; Ghigo, E; Grottoli, S; Maccario, M; Giordano, R.
Affiliation
  • Gasco V; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Giannelli J; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Campioni L; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Arvat E; Division of Oncological Endocrinology, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Ghigo E; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Grottoli S; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Maccario M; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Giordano R; Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences and Department of Clinical and Biological Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. roberta.giordano@unito.it.
J Endocrinol Invest ; 46(3): 587-597, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36251244
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydrocortisone / Adrenal Insufficiency Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2023 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydrocortisone / Adrenal Insufficiency Type of study: Prognostic_studies Limits: Humans Language: En Journal: J Endocrinol Invest Year: 2023 Type: Article Affiliation country: Italy